PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm

The CRISPR Revolution: Redefining Therapeutic Strategy and Pharmaceutical Innovation

For decades, medicine has focused primarily on disease management. Patients with genetic disorders often required lifelong therapy, controlling symptoms but rarely addressing the underlying cause. Genome editing is now transforming that paradigm. CRISPR technology enables precise modification of DNA within human cells, allowing scientists to correct defective genes at their source rather than merely compensating for them. What once seemed like theoretical molecular biology has evolved into a clinically validated therapeutic platform.

For pharmacy and biotechnology professionals, CRISPR is no longer an emerging concept. It is a disruptive force reshaping drug discovery, clinical development, manufacturing strategy
and value-based reimbursement models. Its impact extends well beyond rare genetic diseases, signalling a structural shift in how medicines are designed and delivered.

Understanding CRISPR:
From Bacterial Immunity to Programmable Editing
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) was first identified as part of a bacterial adaptive immune system. Bacteria use CRISPR-associated (Cas) proteins to recognise and cleave viral DNA.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC